Cuéllar Vanessa G, Cuéllar Jason M, Kirsch Thorsten, Strauss Eric J
Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, New York, U.S.A.
Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, New York, U.S.A..
Arthroscopy. 2016 Mar;32(3):475-85. doi: 10.1016/j.arthro.2015.08.033. Epub 2015 Oct 30.
To correlate the intraoperative concentrations of 20 synovial fluid biomarkers with preoperative symptoms, intraoperative findings, and postoperative outcomes in patients undergoing knee arthroscopy, with comparisons made to samples obtained from asymptomatic knees.
Synovial fluid samples were obtained from 81 patients undergoing knee arthroscopy meeting the inclusion criteria, which included 70 samples from operative knees and 32 samples from contralateral knees. Preoperatively, baseline data obtained from clinical questionnaires including a visual analog scale (VAS) score, the Lysholm score, and the Knee Injury and Osteoarthritis Outcome Score-Physical Function Short Form were recorded. Synovial fluid was collected from both the operative knee and asymptomatic contralateral knee. Synovial fluid was stored with a protease inhibitor at -80°C until analysis. Intraoperative findings, procedures performed, and International Cartilage Repair Society (ICRS) cartilage status scores in all operative knees were documented. The concentrations of the following 20 biomarkers were measured using a multiplex magnetic bead immunoassay: matrix metalloproteinase (MMP) 3; MMP-13; tissue inhibitor of metalloproteinase (TIMP) 1; TIMP-2; TIMP-3; TIMP-4; fibroblast growth factor 2; eotaxin; interferon γ; interleukin (IL) 10; platelet-derived growth factor BB; IL-1 receptor antagonist; IL-1β; IL-6; monocyte chemotactic protein 1 (MCP-1); macrophage inflammatory protein 1α; macrophage inflammatory protein 1β; RANTES (regulated upon activation, normal T cell expressed and secreted); tumor necrosis factor α; and vascular endothelial growth factor. Clinical outcome scores were obtained in 83% of patients at a mean of 17 months' follow-up postoperatively. Analysis of variance and Pearson correlation analysis were performed to determine statistical significance between preoperative data, intraoperative findings, postoperative outcomes, and synovial fluid biomarker concentrations compared with asymptomatic contralateral knees.
Analysis was performed on 70 operative and 32 contralateral samples. There were strong positive correlations between ICRS score and age, symptom duration, VAS score, and Knee Injury and Osteoarthritis Outcome Score-Physical Function Short Form. A strong positive correlation was found between MCP-1 and IL-6 concentrations, intraoperative ICRS score, and continued pain at the time of final follow-up. MCP-1 and IL-6 were the strongest predictors of severe cartilage lesions, whereas IL-1 receptor antagonist was inversely related. MMP-3 levels were consistently elevated in all operative samples and directly correlated to increased preoperative VAS scores. RANTES, vascular endothelial growth factor, and platelet-derived growth factor BB were the strongest predictors of postoperative improvement at final follow-up regardless of injury and cartilage status.
Synovial fluid biomarkers have the capacity to reflect the intra-articular environment before surgery and potentially predict postoperative clinical outcomes. Recognition of key molecular players may yield future therapeutic targets, and large clinical trials exploring these discoveries are anticipated.
Level III, therapeutic case-control study.
将20种滑液生物标志物的术中浓度与接受膝关节镜检查患者的术前症状、术中发现及术后结果进行关联,并与从无症状膝关节获取的样本进行比较。
从81例符合纳入标准的接受膝关节镜检查的患者中获取滑液样本,其中包括70例手术膝关节样本和32例对侧膝关节样本。术前,记录从临床问卷中获得的基线数据,包括视觉模拟量表(VAS)评分、Lysholm评分以及膝关节损伤和骨关节炎结果评分-身体功能简表。从手术膝关节和无症状对侧膝关节收集滑液。滑液与蛋白酶抑制剂一起储存在-80°C直至分析。记录所有手术膝关节的术中发现、实施的手术以及国际软骨修复协会(ICRS)软骨状态评分。使用多重磁珠免疫测定法测量以下20种生物标志物的浓度:基质金属蛋白酶(MMP)3;MMP-13;金属蛋白酶组织抑制剂(TIMP)1;TIMP-2;TIMP-3;TIMP-4;成纤维细胞生长因子2;嗜酸性粒细胞趋化因子;干扰素γ;白细胞介素(IL)10;血小板衍生生长因子BB;IL-1受体拮抗剂;IL-1β;IL-6;单核细胞趋化蛋白1(MCP-1);巨噬细胞炎性蛋白1α;巨噬细胞炎性蛋白1β;调节激活正常T细胞表达和分泌的因子(RANTES);肿瘤坏死因子α;以及血管内皮生长因子。83%的患者在术后平均17个月的随访中获得了临床结果评分。进行方差分析和Pearson相关分析,以确定术前数据、术中发现、术后结果以及与无症状对侧膝关节相比的滑液生物标志物浓度之间的统计学意义。
对70例手术样本和32例对侧样本进行了分析。ICRS评分与年龄、症状持续时间、VAS评分以及膝关节损伤和骨关节炎结果评分-身体功能简表之间存在强正相关。发现MCP-1与IL-6浓度、术中ICRS评分以及末次随访时的持续疼痛之间存在强正相关。MCP-1和IL-6是严重软骨损伤的最强预测因子,而IL-1受体拮抗剂与之呈负相关。所有手术样本中的MMP-3水平均持续升高,且与术前VAS评分升高直接相关。无论损伤和软骨状态如何,RANTES、血管内皮生长因子和血小板衍生生长因子BB是末次随访时术后改善的最强预测因子。
滑液生物标志物有能力反映手术前的关节内环境,并有可能预测术后临床结果。识别关键分子参与者可能会产生未来的治疗靶点,预计将开展探索这些发现的大型临床试验。
III级,治疗性病例对照研究。